A Pilot Controlled Trial of Bupropion XL Versus Escitalopram in Generalized Anxiety Disorder

Name: A Pilot Controlled Trial of Bupropion XL Versus Escitalopram in Generalized Anxiety Disorder
SKU: 4109
Price: 30.00 USD
Availability: InStock

$30.00

Alexander Bystritsky, MD Link

ORIGINAL RESEARCH

Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial

Timothy Petersen, PhD, Roy H. Perlis, MD, Chris Ticknor, MD, Jim Lohr, MD, H. Brent Solvason, MD, PhD, John P. O’Reardon, MD, Madelaine M. Wohlreich, MD, Charissa Andreotti, ScB, Michael Wilson, MS, and Maurizio Fava, MD

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 41 No. 1 Articles Tags: alexander-bystritsky, ba, bupropion-hydrochloride, generalized-anxiety-disorder, jamie-d-feusner, lauren-kerwin, md, phd, psychopharmacology

Description

Description

Alexander Bystritsky, MD Link

ORIGINAL RESEARCH

Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial

Timothy Petersen, PhD, Roy H. Perlis, MD, Chris Ticknor, MD, Jim Lohr, MD, H. Brent Solvason, MD, PhD, John P. O’Reardon, MD, Madelaine M. Wohlreich, MD, Charissa Andreotti, ScB, Michael Wilson, MS, and Maurizio Fava, MD

A Pilot Controlled Trial of Bupropion XL Versus Escitalopram in Generalized Anxiety Disorder

Alexander Bystritsky, MD Link

ORIGINAL RESEARCH

Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial

Timothy Petersen, PhD, Roy H. Perlis, MD, Chris Ticknor, MD, Jim Lohr, MD, H. Brent Solvason, MD, PhD, John P. O’Reardon, MD, Madelaine M. Wohlreich, MD, Charissa Andreotti, ScB, Michael Wilson, MS, and Maurizio Fava, MD

Description

Alexander Bystritsky, MD Link

ORIGINAL RESEARCH

Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial

Timothy Petersen, PhD, Roy H. Perlis, MD, Chris Ticknor, MD, Jim Lohr, MD, H. Brent Solvason, MD, PhD, John P. O’Reardon, MD, Madelaine M. Wohlreich, MD, Charissa Andreotti, ScB, Michael Wilson, MS, and Maurizio Fava, MD

Regina C. Casper, MD: How Useful Are Pharmacological Treatments in Eating Disorders?

C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety

Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder

A Pilot Controlled Trial of Bupropion XL Versus Escitalopram in Generalized Anxiety Disorder

Alexander Bystritsky, MD Link

ORIGINAL RESEARCH

Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial

Timothy Petersen, PhD, Roy H. Perlis, MD, Chris Ticknor, MD, Jim Lohr, MD, H. Brent Solvason, MD, PhD, John P. O’Reardon, MD, Madelaine M. Wohlreich, MD, Charissa Andreotti, ScB, Michael Wilson, MS, and Maurizio Fava, MD

Description

Alexander Bystritsky, MD Link

ORIGINAL RESEARCH

Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial

Timothy Petersen, PhD, Roy H. Perlis, MD, Chris Ticknor, MD, Jim Lohr, MD, H. Brent Solvason, MD, PhD, John P. O’Reardon, MD, Madelaine M. Wohlreich, MD, Charissa Andreotti, ScB, Michael Wilson, MS, and Maurizio Fava, MD

Related products

Regina C. Casper, MD: How Useful Are Pharmacological Treatments in Eating Disorders?

C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety

Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder